RESPONSE DISCUSSION

Read your colleagues’ responses below:

Suggest additional actions to take to ensure delivery of safe care.

Provide key components of a Malpractice Policy.

Validate an idea with your own clinical experiences with the support of an additional literature search

Casestudy : Main Discussion Post

James, FNP-BC works with a physician who specializes in pain control. He works in several clinics in the large urban city where he practices. According to the Illinois administrative code, James would need a written collaborative physician agreement specifying his prescriptive authority (ILGA, 2019). The collaborative agreement will need to outline which schedule of controlled substances he may prescribe (ILGA, 2019). James’s collaborative physician must also have a valid and current Illinois controlled substance license and federal registration to delegate James his prescriptive authority (ILGA, 2019). James will require the written delegation within the collaborative physician agreement before he can apply for his Drug Enforcement Administration (DEA) number (ILGA, 2019). The collaborating physician must file the notice of delegation with the Division and the Prescription Monitoring Program; this must occur before James can receive his controlled substances license (ILGA, 2019). In Illinois, the fee for filing for prescriptive authority is $5.00 (ILGA, 2019).

Since James works in several clinics, a copy of the collaborative physician agreement must be in the collaborative physician’s office, and each location that James works (ILGA, 2019). If James writes a prescription, the collaborative physician’s name must be included, as well as the specification of a brand or generic medication; James may sign the script (ILGA, 2019). James may only prescribe the Schedule II controlled substances that his collaborative physician prescribes with no more than a 30-day supply and requires intermittent review by his collaborating physician (ILGA, 2019). According to the administrative code, James may only prescribe Schedule II controlled substances given by oral, topical, or transdermal routes (ILGA, 2019). The prescriptive authority allows James to receive and dispense samples but does not provide authority to practice within a hospital or ambulatory surgical center (ILGA, 2019).

To apply for his DEA number, James will need to obtain the DEA form-224 either online or by calling the Registration Section at the DEA office (U. S. Department of Justice [DoJ], n. d.). According to the Illinois Department of Financial and Professional Regulations (IDFPR) (n. d.), James will require his advance practice nurse license, an official transcript with school seal affixed, and completion of 45 graduate hours in pharmacology to accompany his completed form. The Title 21 Code of Federal Regulations indicates that the fee for obtaining a DEA number is $731 (DoJ, n. d.).

References

ILGA. (2019, June 14). Administrative Code. Retrieved from http://www.ilga.gov/commission/jcar/admincode/068/068013000D04300R.html

Illinois Department of Financial and Professional Regulations. (n.d.). (309) Advanced Practice Nurse Controlled Substance License. Retrieved from https://www.idfpr.com/Forms/Online/(309) APN Controlled Substance User Guide.pdf

U. S. Department of Justice. (n.d.). Registration Procedures. Retrieved from https://www.deadiversion.usdoj.gov/drugreg/process.htm

U. S. Department of Justice. (n.d.). Title 21 Code of Federal Regulations. Retrieved from https://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_13.htm#feeCategories

.